United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64380-754_4dcf85f4-ed27-4fba-a2e3-95a3b8a89b86
- Product NDC
- 64380-754
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Strides Pharma Science Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250108
- Source listing expiry
- 20271231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE, PLASTIC (64380-754-01) · 64380-754-01
- 500 CAPSULE in 1 BOTTLE, PLASTIC (64380-754-02) · 64380-754-02
- 1000 CAPSULE in 1 BOTTLE, PLASTIC (64380-754-03) · 64380-754-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →